SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-302228
Filing Date
2023-12-22
Accepted
2023-12-22 17:18:30
Documents
15
Period of Report
2023-12-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d199412d8k.htm   iXBRL 8-K 46708
2 EX-2.1 d199412dex21.htm EX-2.1 390729
3 EX-10.1 d199412dex101.htm EX-10.1 22378
  Complete submission text file 0001193125-23-302228.txt   710055

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA sqzb-20231221.xsd EX-101.SCH 3216
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sqzb-20231221_def.xml EX-101.DEF 14143
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE sqzb-20231221_lab.xml EX-101.LAB 23238
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sqzb-20231221_pre.xml EX-101.PRE 15019
9 EXTRACTED XBRL INSTANCE DOCUMENT d199412d8k_htm.xml XML 5381
Mailing Address 200 ARSENAL YARDS BLVD., STE. 210 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., STE. 210 WATERTOWN MA 02472 617-898-8824
SQZ Biotechnologies Co (Filer) CIK: 0001604477 (see all company filings)

IRS No.: 462431115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39662 | Film No.: 231510822
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)